Literature DB >> 15840698

Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.

Cristiana Bellan1, Stefano Lazzi, Michael Hummel, Nazzareno Palummo, Margherita de Santi, Teresa Amato, Joshua Nyagol, Elena Sabattini, Thierry Lazure, Stefano A Pileri, Martine Raphael, Harald Stein, Piero Tosi, Lorenzo Leoncini.   

Abstract

The normal counterpart of the neoplastic B cells in Burkitt lymphoma (BL) is still unclear. Based on immunoglobulin gene rearrangement studies, some authors suggest an origin from germinal center cells and others from memory B cells. However, most of these studies rely on cell lines or on a small series of cases. To help clarify the cell of origin of BL, semi-nested polymerase chain reaction (PCR) was performed to amplify the VDJ rearrangements of the immunoglobulin heavy chain (V(H)) genes, and the resultant amplificates were sequenced for comparison with known germline V(H) segments. The results of this approach revealed that all cases (15 endemic BL [eBL], 10 sporadic BL [sBL], and 6 AIDS-related BL) harbor mutated V(H) genes, with different mutation ranges among the 3 types of BL. The eBL and AIDS-related forms showed considerably higher mutation rates than the sBL form (5.1%, 5.4%, and 1.5%, respectively). The mutations in eBL and AIDS-related BL also showed signs of antigen selection, whereas no signs of antigen selection were found in sBL. Finally, after subcloning the amplificates, sequence analysis revealed no signs of ongoing mutations in any of the cases analyzed. Given that one of the main differences between eBL and AIDS-related BL on the one hand and sBL on the other hand is the association with Epstein-Barr virus (EBV), we compared EBV-positive and EBV-negative BLs independently of their geographic origin and HIV status. The differences in the number of somatic mutations and antigen selection were even more evident when this approach was used. According to our molecular results, it appears that EBV-positive and EBV-negative BL may originate from 2 distinct subsets of B cells, pointing to a particular role for the germinal-center reaction in the pathogenesis of these tumors. The different types of C-MYC translocation reported in BL may also be related to the different stages of B-cell maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840698     DOI: 10.1182/blood-2005-01-0168

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Authors:  Daniel Salamon; Monika Adori; Dorina Ujvari; Liang Wu; Lorand L Kis; Harsha S Madapura; Noemi Nagy; George Klein; Eva Klein
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 2.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 3.  Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

Authors:  Kikkeri N Naresh; Martine Raphael; Leona Ayers; Nina Hurwitz; Valeria Calbi; Emily Rogena; Shahin Sayed; Omar Sherman; Hazem A H Ibrahim; Stefano Lazzi; Vasileios Mourmouras; Patricia Rince; Jessie Githanga; Bessie Byakika; Emma Moshi; Muheez Durosinmi; Babatunde J Olasode; Olayiwola A Oluwasola; Effiong E Akang; Yetunde Akenòva; Melissa Adde; Ian Magrath; Lorenzo Leoncini
Journal:  Br J Haematol       Date:  2011-06-28       Impact factor: 6.998

4.  The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.

Authors:  D Lenze; L Leoncini; M Hummel; S Volinia; C G Liu; T Amato; G De Falco; J Githanga; H Horn; J Nyagol; G Ott; J Palatini; M Pfreundschuh; E Rogena; A Rosenwald; R Siebert; C M Croce; H Stein
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

5.  High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis.

Authors:  Katharine A Lombardo; David G Coffey; Alicia J Morales; Christopher S Carlson; Andrea M H Towlerton; Sarah E Gerdts; Francis K Nkrumah; Janet Neequaye; Robert J Biggar; Jackson Orem; Corey Casper; Sam M Mbulaiteye; Kishor G Bhatia; Edus H Warren
Journal:  Blood Adv       Date:  2017-03-21

6.  Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.

Authors:  Gabriela Gualco; Eduardo M Queiroga; Lawrence M Weiss; Claudete E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2009-01-13       Impact factor: 3.466

7.  AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus.

Authors:  Joel R Wilmore; Amolo S Asito; Chungwen Wei; Erwan Piriou; P Odada Sumba; Iñaki Sanz; Rosemary Rochford
Journal:  Int J Cancer       Date:  2014-08-19       Impact factor: 7.396

8.  Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.

Authors:  Anna Onnis; Giulia De Falco; Giuseppina Antonicelli; Monica Onorati; Cristiana Bellan; Omar Sherman; Shaheen Sayed; Lorenzo Leoncini
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

9.  Immune surveillance and lymphoid malignancy in immunocompromised host.

Authors:  Patrick L Stevens; Nishitha M Reddy
Journal:  Am J Blood Res       Date:  2013-05-05

10.  Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.

Authors:  Thomas Burmeister; Mara Molkentin; Stefan Schwartz; Nicola Gökbuget; Dieter Hoelzer; Eckhard Thiel; Richard Reinhardt
Journal:  Mol Oncol       Date:  2013-04-25       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.